Download PDF
J Knee Surg 2019; 32(01): 037-045
DOI: 10.1055/s-0038-1675170
Special Focus Section
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Use of Platelet-Rich Plasma in Symptomatic Knee Osteoarthritis

Taylor M. Southworth
1   Division of Sports Medicine, Department of Orthopedics, Rush University Medical Center, Chicago, Illinois
,
Neal B. Naveen
1   Division of Sports Medicine, Department of Orthopedics, Rush University Medical Center, Chicago, Illinois
,
Tracy M. Tauro
1   Division of Sports Medicine, Department of Orthopedics, Rush University Medical Center, Chicago, Illinois
,
Natalie L. Leong
1   Division of Sports Medicine, Department of Orthopedics, Rush University Medical Center, Chicago, Illinois
,
Brian J. Cole
1   Division of Sports Medicine, Department of Orthopedics, Rush University Medical Center, Chicago, Illinois
› Author Affiliations
Further Information

Publication History

04 July 2018

07 September 2018

Publication Date:
13 November 2018 (online)

    Permissions and Reprints

Abstract

With average life expectancy and the rising prevalence of obesity, osteoarthritis (OA) is creating an increasingly large financial and physical burden on the U.S. population today. As the body ages and experiences trauma, articular cartilage surfaces in joints are gradually worn away, leading to OA. Traditionally, treatment options have included lifestyle modifications, pain management, and corticosteroid injections, with joint replacement reserved for those who have exhausted nonsurgical measures. More recently, hyaluronic acid, micronized dehydrated human amniotic/chorionic membrane tissue, and platelet-rich plasma (PRP) injections have started to gain traction. PRP has been shown to have both anti-inflammatory effects through growth factors such as transforming growth factor-β and insulin-like growth factor 1, and stimulatory effects on mesenchymal stem cells and fibroblasts. Multiple studies have indicated that PRP is superior to hyaluronic acid and corticosteroids in terms of improving patient-reported pain and functionality scores. Unfortunately, there are many variations in PRP preparation, and lack of standardization in factors, such as speed and duration of centrifugation, leads to wide ranges of platelet and leukocyte concentrations. This review examines the current literature addressing the use of PRP in symptomatic knee OA and addresses suggestions for future studies in this area.

Keywords

knee - articular cartilage - articular cartilage restoration
 

  • References

  • 1 Sakata R, Iwakura T, Reddi AH. Regeneration of articular cartilage surface: morphogens, cells, and extracellular matrix scaffolds. Tissue Eng Part B Rev 2015; 21 (05) 461-473
    CrossrefPubMedSearch in Google Scholar
  • 2 Musumeci G, Aiello FC, Szychlinska MA, Di Rosa M, Castrogiovanni P, Mobasheri A. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. Int J Mol Sci 2015; 16 (03) 6093-6112
    CrossrefPubMedSearch in Google Scholar
  • 3 Drengk A, Zapf A, Stürmer EK, Stürmer KM, Frosch KH. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 2009; 189 (05) 317-326
    CrossrefPubMedSearch in Google Scholar
  • 4 Halpern B, Chaudhury S, Rodeo SA. , et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med 2013; 23 (03) 238-239
    CrossrefPubMedSearch in Google Scholar
  • 5 Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol 2006; 33 (11) 2271-2279
    PubMedSearch in Google Scholar
  • 6 Rahimzadeh P, Imani F, Faiz SHR, Entezary SR, Zamanabadi MN, Alebouyeh MR. The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clin Interv Aging 2018; 13: 73-79
    CrossrefPubMedSearch in Google Scholar
  • 7 Zhang W, Moskowitz RW, Nuki G. , et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16 (02) 137-162
    CrossrefPubMedSearch in Google Scholar
  • 8 Cole BJ, Karas V, Hussey K, Pilz K, Fortier LA. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med 2017; 45 (02) 339-346
    CrossrefPubMedSearch in Google Scholar
  • 9 Willett NJ, Thote T, Lin ASP. , et al. Intra-articular injection of micronized dehydrated human amnion/chorion membrane attenuates osteoarthritis development. Arthritis Res Ther 2014; 16 (01) R47
    CrossrefPubMedSearch in Google Scholar
  • 10 Gellhorn AC, Han A. The use of dehydrated human amnion/chorion membrane allograft injection for the treatment of tendinopathy or arthritis: a case series involving 40 patients. PM R 2017; 9 (12) 1236-1243
    CrossrefPubMedSearch in Google Scholar
  • 11 Liu S-H, Dubé CE, Eaton CB, Driban JB, McAlindon TE, Lapane KL. Longterm effectiveness of intraarticular injections on patient-reported symptoms in knee osteoarthritis. J Rheumatol 2018; 45 (09) 1316-1324
    PubMedSearch in Google Scholar
  • 12 Cervelli V, Gentile P, Scioli MG. , et al. Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods 2009; 15 (04) 625-634
    PubMedSearch in Google Scholar
  • 13 Del Fabbro M, Bortolin M, Taschieri S, Weinstein R. Is platelet concentrate advantageous for the surgical treatment of periodontal diseases? A systematic review and meta-analysis. J Periodontol 2011; 82 (08) 1100-1111
    CrossrefPubMedSearch in Google Scholar
  • 14 Frykberg RG, Driver VR, Carman D. , et al. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Ostomy Wound Manage 2010; 56 (06) 36-44
    PubMedSearch in Google Scholar
  • 15 Lee Z-H, Sinno S, Poudrier G. , et al. Platelet rich plasma for photodamaged skin: a pilot study. J Cosmetol Dermatology 2018; (e-pub ahead of print).
    PubMedSearch in Google Scholar
  • 16 Hastie G, Soufi M, Wilson J, Roy B. Platelet rich plasma injections for lateral epicondylitis of the elbow reduce the need for surgical intervention. J Orthop 2018; 15 (01) 239-241
    PubMedSearch in Google Scholar
  • 17 Lim W, Park SH, Kim B, Kang SW, Lee JW, Moon YL. Relationship of cytokine levels and clinical effect on platelet-rich plasma-treated lateral epicondylitis. J Orthop Res 2018; 36 (03) 913-920
    PubMedSearch in Google Scholar
  • 18 Sun Y, Feng Y, Zhang CQ, Chen SB, Cheng XG. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 2010; 34 (04) 589-597
    CrossrefPubMedSearch in Google Scholar
  • 19 Simental-Mendía MA, Vílchez-Cavazos JF, Martínez-Rodríguez HG. Platelet-rich plasma in knee osteoarthritis treatment [in Spanish]. Cir Cir 2015; 83 (04) 352-358
    PubMedSearch in Google Scholar
  • 20 Pourcho AM, Smith J, Wisniewski SJ, Sellon JL. Intraarticular platelet-rich plasma injection in the treatment of knee osteoarthritis: review and recommendations. Am J Phys Med Rehabil 2014; 93 (11) (Suppl. 03) S108-S121
    CrossrefPubMedSearch in Google Scholar
  • 21 Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009; 37 (11) 2259-2272
    CrossrefPubMedSearch in Google Scholar
  • 22 Delong JM, Beitzel K, Mazzocca AD, Shepard D, Roller BL, Hanypsiak BT. Update on platelet-rich plasma. Sports Med 2011; 22 (06) 514-523
    PubMedSearch in Google Scholar
  • 23 Wu Y, Kanna MS, Liu C, Zhou Y, Chan CK. Generation of autologous platelet-rich plasma by the ultrasonic standing waves. IEEE Trans Biomed Eng 2016; 63 (08) 1642-1652
    CrossrefPubMedSearch in Google Scholar
  • 24 Senzel L, Gnatenko DV, Bahou WF. The platelet proteome. Curr Opin Hematol 2009; 16 (05) 329-333
    CrossrefPubMedSearch in Google Scholar
  • 25 Getgood A, Henson F, Brooks R, Fortier LA, Rushton N. Platelet-rich plasma activation in combination with biphasic osteochondral scaffolds-conditions for maximal growth factor production. Knee Surg Sports Traumatol Arthrosc 2011; 19 (11) 1942-1947
    CrossrefPubMedSearch in Google Scholar
  • 26 Bendinelli P, Matteucci E, Dogliotti G. , et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol 2010; 225 (03) 757-766
    CrossrefPubMedSearch in Google Scholar
  • 27 Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The role of growth factors in cartilage repair. Clin Orthop Relat Res 2011; 469 (10) 2706-2715
    CrossrefPubMedSearch in Google Scholar
  • 28 Shuler FD, Georgescu HI, Niyibizi C. , et al. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res 2000; 18 (04) 585-592
    CrossrefPubMedSearch in Google Scholar
  • 29 Madry H, Zurakowski D, Trippel SB. Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation. Gene Ther 2001; 8 (19) 1443-1449
    PubMedSearch in Google Scholar
  • 30 Madry H, Emkey G, Zurakowski D, Trippel SB. Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation. J Gene Med 2004; 6 (02) 238-245
    CrossrefPubMedSearch in Google Scholar
  • 31 Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 2006; 14 (05) 403-412
    CrossrefPubMedSearch in Google Scholar
  • 32 Song SU, Cha YD, Han JU. , et al. Hyaline cartilage regeneration using mixed human chondrocytes and transforming growth factor-beta1- producing chondrocytes. Tissue Eng 2005; 11 (9-10): 1516-1526
    CrossrefPubMedSearch in Google Scholar
  • 33 Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85 (06) 638-646
    CrossrefPubMedSearch in Google Scholar
  • 34 Wasterlain AS, Braun HJ, Harris AHS, Kim H-J, Dragoo JL. The systemic effects of platelet-rich plasma injection. Am J Sports Med 2013; 41 (01) 186-193
    CrossrefPubMedSearch in Google Scholar
  • 35 Yerlikaya M, Talay Çaliş H, Tomruk Sütbeyaz S. , et al. Comparison of effects of leukocyte-rich and leukocyte-poor platelet-rich plasma on pain and functionality in patients with lateral epicondylitis. Arch Rheumatol 2017; 33 (01) 73-79
    PubMedSearch in Google Scholar
  • 36 Lee HR, Park KM, Joung YK, Park KD, Do SH. Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2. J Control Release 2012; 159 (03) 332-337
    CrossrefPubMedSearch in Google Scholar
  • 37 Kon E, Mandelbaum B, Buda R. , et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011; 27 (11) 1490-1501
    CrossrefPubMedSearch in Google Scholar
  • 38 Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013; 41 (02) 356-364
    CrossrefPubMedSearch in Google Scholar
  • 39 van Buul GM, Koevoet WLM, Kops N. , et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med 2011; 39 (11) 2362-2370
    CrossrefPubMedSearch in Google Scholar
  • 40 Pujol JP, Chadjichristos C, Legendre F. , et al. Interleukin-1 and transforming growth factor-β 1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res 2008; 49 (03) 293-297
    CrossrefPubMedSearch in Google Scholar
  • 41 Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27 (03) 158-167
    CrossrefPubMedSearch in Google Scholar
  • 42 Magalon J, Bausset O, Serratrice N. , et al. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy 2014; 30 (05) 629-638
    CrossrefPubMedSearch in Google Scholar
  • 43 Fitzpatrick J, Bulsara MK, McCrory PR, Richardson MD, Zheng MH. Analysis of platelet-rich plasma extraction: variations in platelet and blood components between 4 common commercial kits. Orthop J Sports Med 2017; 5 (01) 1-8
    Search in Google Scholar
  • 44 Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health 2012; 4 (02) 162-172
    CrossrefPubMedSearch in Google Scholar
  • 45 Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 2011; 39 (10) 2135-2140
    CrossrefPubMedSearch in Google Scholar
  • 46 Mazzocca AD, McCarthy MBR, Chowaniec DM. , et al. The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Am J Sports Med 2012; 40 (08) 1742-1749
    CrossrefPubMedSearch in Google Scholar
  • 47 Filardo G, Kon E, Pereira Ruiz MT. , et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc 2012; 20 (10) 2082-2091
    CrossrefPubMedSearch in Google Scholar
  • 48 Efeoglu C, Akçay YD, Ertürk S. A modified method for preparing platelet-rich plasma: an experimental study. J Oral Maxillofac Surg 2004; 62 (11) 1403-1407
    CrossrefPubMedSearch in Google Scholar
  • 49 Lippi G, Salvagno GL, Montagnana M, Poli G, Guidi GC. Influence of the needle bore size on platelet count and routine coagulation testing. Blood Coagul Fibrinolysis 2006; 17 (07) 557-561
    CrossrefPubMedSearch in Google Scholar
  • 50 Oudelaar BW, Peerbooms JC, Huis In 't Veld R, Vochteloo AJH. Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature. Am J Sports Med 2018; 036354651774611: 363546517746112
    PubMedSearch in Google Scholar
  • 51 Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med 2016; 44 (03) 792-800
    CrossrefPubMedSearch in Google Scholar
  • 52 Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med 2014; 42 (05) 1204-1210
    CrossrefPubMedSearch in Google Scholar
  • 53 Giusti I, Di Francesco M, D'Ascenzo S. , et al. Leukocyte depletion does not affect the in vitro healing ability of platelet rich plasma. Exp Ther Med 2018; 15 (04) 4029-4038
    PubMedSearch in Google Scholar
  • 54 Raeissadat SA, Rayegani SM, Babaee M, Ghorbani E. The effect of platelet-rich plasma on pain, function, and quality of life of patients with knee osteoarthritis. Pain Res Treat 2013; 2013 (13) 165967
    PubMedSearch in Google Scholar
  • 55 Felisaz N, Boumediene K, Ghayor C. , et al. Stimulating effect of diacerein on TGF-β1 and β2 expression in articular chondrocytes cultured with and without interleukin-1. Osteoarthritis Cartilage 1999; 7 (03) 255-264
    CrossrefPubMedSearch in Google Scholar
  • 56 Roman-Blas JA, Stokes DG, Jimenez SA. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage 2007; 15 (12) 1367-1377
    CrossrefPubMedSearch in Google Scholar
  • 57 Jo CH, Shin JS, Lee SY, Shin S. Allogeneic platelet-rich plasma for rotator cuff repair. Acta Ortop Bras 2017; 25 (01) 38-43
    CrossrefPubMedSearch in Google Scholar
  • 58 Anitua E, Prado R, Orive G. Allogeneic platelet-rich plasma: at the dawn of an off-the-shelf therapy?. Trends Biotechnol 2017; 35 (02) 91-93
    CrossrefPubMedSearch in Google Scholar
  • 59 Bottegoni C, Dei Giudici L, Salvemini S, Chiurazzi E, Bencivenga R, Gigante A. Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study. Ther Adv Musculoskelet Dis 2016; 8 (02) 35-41
    CrossrefPubMedSearch in Google Scholar
  • 60 Wilson BH, Cole BJ, Goodale MB, Fortier LA. Short-term storage of platelet-rich plasma at room temperature does not affect growth factor or catabolic cytokine concentration. Am J Orthop 2018; 47 (04) 10-12
    PubMedSearch in Google Scholar
  • 61 Bausset O, Giraudo L, Veran J. , et al. Formulation and storage of platelet-rich plasma homemade product. Biores Open Access 2012; 1 (03) 115-123
    CrossrefPubMedSearch in Google Scholar
  • 62 Wen YH, Lin WY, Lin CJ. , et al. Sustained or higher levels of growth factors in platelet-rich plasma during 7-day storage. Clin Chim Acta 2018; 483: 89-93
    CrossrefPubMedSearch in Google Scholar
  • 63 Alessio-Mazzola M, Repetto I, Biti B, Trentini R, Formica M, Felli L. Autologous US-guided PRP injection versus US-guided focal extracorporeal shock wave therapy for chronic lateral epicondylitis: a minimum of 2-year follow-up retrospective comparative study. J Orthop Surg (Hong Kong) 2018; 26 (01) 1-8
    PubMedSearch in Google Scholar
  • 64 Smith PA. Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis. Am J Sports Med 2016; 44 (04) 884-891
    CrossrefPubMedSearch in Google Scholar
  • 65 Raeissadat SA, Rayegani SM, Hassanabadi H. , et al. Knee osteoarthritis injection choices: platelet-rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord 2015; 8: 1-8
    PubMedSearch in Google Scholar
  • 66 Lana JF, Weglein A, Sampson SE. , et al. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. J Stem Cells Regen Med 2016; 12 (02) 69-78
    Search in Google Scholar
  • 67 Russo F, D'Este M, Vadalà G. , et al. Platelet rich plasma and hyaluronic acid blend for the treatment of osteoarthritis: rheological and biological evaluation. PLoS One 2016; 11 (06) 1-12
    CrossrefPubMedSearch in Google Scholar
  • 68 Forogh B, Mianehsaz E, Shoaee S, Ahadi T, Raissi GR, Sajadi S. Effect of single injection of platelet-rich plasma in comparison with corticosteroid on knee osteoarthritis: a double-blind randomized clinical trial. J Sports Med Phys Fitness 2016; 56 (7-8): 901-908
    PubMedSearch in Google Scholar
  • 69 Huang PH, Wang CJ, Chou WY, Wang JW, Ko JY. Short-term clinical results of intra-articular PRP injections for early osteoarthritis of the knee. Int J Surg 2017; 42: 117-122
    CrossrefPubMedSearch in Google Scholar
  • 70 Cohen DB, Kawamura S, Ehteshami JR, Rodeo SA. Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing. Am J Sports Med 2006; 34 (03) 362-369
    CrossrefPubMedSearch in Google Scholar
  • 71 Meadows MC, Levy DM, Ferry CM, Gardner TR, Teratani T, Ahmad CS. Effects of platelet-rich plasma and indomethacin on biomechanics of rotator cuff repair. Am J Orthop (Belle Mead NJ) 2017; 46 (05) E336-E343
    PubMedSearch in Google Scholar
  • 72 Nall R. What you need to know about PRP. Medical News Today. November 2017. https://www.medicalnewstoday.com/articles/320107.php
    PubMed
  • 73 Electronic Code of Federal Regulations. Title 21: Food and Drugs. Part 640: Additional Standards for Human Blood and Blood Products. Subpart D: Plasma §640.34 Processing. https://www.ecfr.gov/cgi-bin/text-idx?SID=b2597f11cca80b9d42015e246bbb54c6&mc=true&node=se21.7.640_134&rgn=div8 . Published 2018. Accessed August 15, 2018
    PubMed
  • 74 FDA. 510(k) Clearance. Available at: https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketNotification510k/default.htm . Accessed October 29, 2018
    PubMed